17:09 EDT BioAffinity Technologies (BIAF) files to sell 497,483 shares of common stock for holder
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIAF:
- BioAffinity Technologies launches new study to expand use of CyPath lung tech
- bioAffinity Highlights CyPath Lung Case Avoiding Unnecessary Biopsy
- BioAffinity Technologies releases clinical case on CyPath Lung
- bioAffinity Showcases CyPath Lung Test at Cleveland Clinic
- BioAffinity announces CyPath Lung to be featured at Cleveland Clinic symposium